Literature DB >> 1900971

Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.

S Toyosawa1, Y Ogawa, C K Chang, S S Hong, T Yagi, H Kuwahara, K Wakasa, M Sakurai.   

Abstract

Using routinely processed, paraffin-embedded tissue specimens, osteoclast-like giant cells in giant cell tumour of bone (GCT), chondroblastoma, osteoblastoma and osteoblastic osteosarcoma were examined histochemically for osteoclast-specific enzymes tartrate-resistant acid phosphatase (TRAP) and carbonic anhydrase isoenzyme II (CA-II). Osteoclast-like giant cells and some mononuclear cells possessed TRAP activity. These were further classified with respect to CA-II immunoreactivity, i.e. cells with CA-II were seen in GCT and chondroblastoma, while those in osteoblastoma and osteoblastic osteosarcoma were negative for CA-II. All the cellular components in malignant fibrous histiocytoma and various extraosseous inflammatory lesions including malignant giant cells and macrophage polykaryons were negative for both TRAP and CA-II. These results indicate that osteoclast-like giant cells in GCT, chondroblastoma, osteoblastoma and osteoblastic osteosarcoma are all osteoclasts and generated by fusion of mononuclear cells with the same histochemical characteristics as osteoclast-like giant cells. The difference in CA-II immunoreactivity suggests the functional or maturational difference between osteoclast-like giant cells in GCT and chondroblastoma and those in osteoblastoma and osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900971     DOI: 10.1007/bf01606064

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  23 in total

1.  Inhibition of bone resorption by acetazolamide in the rat.

Authors:  L C Waite; W A Volkert; A D Kenny
Journal:  Endocrinology       Date:  1970-12       Impact factor: 4.736

2.  Cellular differences in acid phosphatase isoenzymes in bone and teeth.

Authors:  L E Hammarström; J S Hanker; S U Toverud
Journal:  Clin Orthop Relat Res       Date:  1971       Impact factor: 4.176

3.  Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts.

Authors:  R Baron; L Neff; P Tran Van; J R Nefussi; A Vignery
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

Review 4.  Characterization of cells from human giant cell tumors of bone.

Authors:  S R Goldring; A L Schiller; H J Mankin; J M Dayer; S M Krane
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

5.  Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification.

Authors:  F P van de Wijngaert; E H Burger
Journal:  J Histochem Cytochem       Date:  1986-10       Impact factor: 2.479

6.  Giant cell tumor bone. Enzyme histochemical, biochemical and tissue culture studies.

Authors:  H Yoshida; M Akeho; T Yumoto
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Immunohistochemical localization of carbonic anhydrase isoenzymes I and II in human bone, cartilage and giant cell tumor.

Authors:  H K Väänänen
Journal:  Histochemistry       Date:  1984

8.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

Authors:  W S Sly; D Hewett-Emmett; M P Whyte; Y S Yu; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Carbonic anhydrase and bone remodeling: sulfonamide inhibition of bone resorption in organ culture.

Authors:  C Minkin; J M Jennings
Journal:  Science       Date:  1972-06-02       Impact factor: 47.728

10.  Stable acid phosphatase: I. Demonstration and distribution.

Authors:  F M Eggert; J P Germain
Journal:  Histochemistry       Date:  1980
View more
  7 in total

1.  Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.

Authors:  K Metze
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment.

Authors:  L Huang; Y Y Cheng; L T C Chow; M H Zheng; S M Kumta
Journal:  Mol Pathol       Date:  2003-04

3.  Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.

Authors:  M H Zheng; Y Fan; S J Wysocki; A T Lau; T Robertson; M Beilharz; D J Wood; J M Papadimitriou
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.

Authors:  Y Ueda; K Imai; H Tsuchiya; N Fujimoto; I Nakanishi; S Katsuda; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

5.  Cell cytoskeleton and proliferation study for the RANKL-induced RAW264.7 differentiation.

Authors:  Lingbo Kong; Rui Ma; Yang Cao; Wanli Smith; Yuan Liu; Xiaobin Yang; Liang Yan
Journal:  J Cell Mol Med       Date:  2021-03-19       Impact factor: 5.310

6.  Trabecular bone loss in collagen antibody-induced arthritis.

Authors:  Louise Grahnemo; Annica Andersson; Merja Nurkkala-Karlsson; Alexandra Stubelius; Marie K Lagerquist; Mattias N D Svensson; Claes Ohlsson; Hans Carlsten; Ulrika Islander
Journal:  Arthritis Res Ther       Date:  2015-07-25       Impact factor: 5.156

7.  Interleukin 17A: a Janus-faced regulator of osteoporosis.

Authors:  J M Scheffler; L Grahnemo; C Engdahl; C Drevinge; K L Gustafsson; C Corciulo; L Lawenius; Y Iwakura; K Sjögren; M K Lagerquist; H Carlsten; C Ohlsson; U Islander
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.